Skip to main content
Clinical Trials/NCT03760224
NCT03760224CompletedNot Applicable

Effectiveness of WhatsApp Online Group Discussion for Smoking Relapse Prevention: a Pragmatic Randomized Controlled Trial

The University of Hong Kong1 site in 1 country928 target enrollmentStarted: October 4, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
928
Locations
1
Primary Endpoint
Number of Participants Who Passed the Biochemical Validated Abstinence at 12-month Follow-up

Study Overview

Brief Summary

This study aims to examine the effectiveness and cost-effectiveness of WhatsApp group discussion for smoking relapse prevention. To assess the effect due to treatment modality through the WhatsApp social group, the frequency and topics of the posts in each social group will be analysed and in each participant. The primary hypothesis is whether quitters who participate in the WhatsApp group discussion will have a higher prevalence of validated tobacco abstinence at 12-month follow-up than those who do not. The second hypothesis is that greater participation in the social groups, indicated by number of posts received, posted and/or viewed, was associated with higher likelihood to quit at 12-month. The third hypothesis is that the WhatsApp intervention for a recent quitter is a more cost-effective option for tobacco abstinence and prolonged survival when compared to the control group.

Detailed Description

Study design:

This is a 2-arm open-labelled pragmatic randomized controlled trial, by comparing the 12-month tobacco abstinence between the recent quitters who will join WhatsApp group discussion (Intervention group) and those who will not (Control group). A 1:1 randomised allocation will be used. The intervention content for both trial arms in the proposed trial will be the same and based on the US practice guidelines for smoking cessation, therefore the intervention effects due to the treatment content will be the same in both groups. Only the intervention platform (WhatsApp vs text messaging service) and the communication mode (one-way vs interactive) will be different between the 2 groups. This trial will be a pragmatic effectiveness trial to examine the effect of our intervention delivered under a real-life setting. A less stringent eligibility criteria will be applied for the subjects, unobtrusive measurement on adherence, and include all subjects in the final analysis regardless of intervention compliance of each subject.

Subjects:

Patients who are receiving the smoking cessation service in the smoking cessation clinic of the Queen Elizabeth Hospital, Tung Wah Groups of Hospital, Shau Kei Wan Jockey Club Outpatient Clinic, Sai Ying Pun Jockey Club Outpatient Clinic and Pok Oi Chinese medicine clinic. Smoking Cessation Service will be invited to go through the screening process. These clinics are under Hospital Authority (n=3), or are non-governmental organizations that are funded by the government (n=7). Patients with the following inclusion criteria will be invited to participate in the RCT and will proceed to the recruitment procedure and intervention phase (Phase 2).

  1. Daily tobacco user before service intake
  2. Aged 18 years or above
  3. Have enrolled or re-enrolled in the smoking cessation treatment for no more than 8 weeks
  4. Not using tobacco products (including traditional cigarettes and heat-not-burn tobacco products) for 3 to 30 days
  5. Able to communicate in Cantonese/Mandarin and read Chinese
  6. Have a smart phone with local network connection The 4th criterion will be used because our proposed RCT will target the quitters who have recently quit, and exclude those who will have maintained a longer period of abstinence.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Daily tobacco user before service intake
  • •Aged 18 years or above
  • •Have enrolled or re-enrolled in the smoking cessation treatment for no more than 8 weeks
  • •Not using tobacco products (including traditional cigarettes and heat-not-burn tobacco products) for 3 to 30 days
  • •Able to communicate in Cantonese/Mandarin and read Chinese
  • •Have a smart phone with local network connection

Exclusion Criteria

  • •Do not use WhatsApp as communication tool and show no interest to use WhatsApp
  • •Have unstable physical or psychological conditions as advised by doctors or counsellor in charge
  • •Have become pregnant in the past 2 months

Arms & Interventions

Intervention

Experimental

WhatsApp group will receive at least 3 messages each week and allow real-time group discussion for the intervention period (8 weeks).

Intervention: WhatsApp group (Other)

Control

Active Comparator

The control group will receive 3 mobile phone text messages each week in the 8 weeks after recruitment. This will be a one way message and no real-time discussion will be available.

Intervention: SMS group (Other)

Outcomes

Primary Outcomes

Number of Participants Who Passed the Biochemical Validated Abstinence at 12-month Follow-up

Time Frame: 12 month

Exhaled carbon monoxide below 4ppm using a Smokerlyzer, and a saliva cotinine 10ng/ml or below using the iScreen OFD Cotinine Saliva Test Kit

Secondary Outcomes

  • Number of Participants Who Passed the Biochemical Validated Abstinence at 6-month Follow-up(6 month)
  • Number of Participants Who Reported Smoking Relapse at 3-month Follow-up(3 month)
  • Number of Participants Who Reported Smoking Relapse at 6-month Follow-up(6 month)
  • Number of Participants Who Reported Smoking Relapse at 12-month Follow-up(12 month)
  • Number of Participants Who Self-reported Continuous Abstinence(12 month)
  • Number of Participants Who Self-reported 7-day Abstinence at 3-month Follow-up(3 month)
  • Number of Participants Self-reported 7-day Abstinence at 6-month Follow-up(6 month)
  • Number of Participants Self-reported 7-day Abstinence at 12-month Follow-up(12 month)
  • Number of Participants Who Reported Self-reported Continuous Abstinence(3 month)
  • Number of Participants Who Self-reported Continuous Abstinence(6 month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Derek Yee-Tak Cheung

Research Assistant Professor

The University of Hong Kong

Study Sites (1)

Loading locations...

Similar Trials